Alert-EmergencyArtboard 1

Urgent Provider Notification Regarding Ascension Cyber Event

November 2022 Test Bulletin

November 15, 2022

The bulletin from Alverno Laboratories contains three important updates for healthcare providers. Firstly, effective November 2, 2022, deamidated gliadin and tissue transglutaminase testing will be performed using a new chemiluminescent methodology, maintaining the reference cutoff for negative results at <20 Units. Secondly, there's a notice regarding the "Preventing Harm Test Code," emphasizing the clinician's responsibility in determining the release of lab results in compliance with applicable laws, with Alverno not responsible for such determinations. Finally, starting January 1, 2023, the Internet Explorer browser will no longer be supported for clients using the electronic system on the Alverno website, urging them to switch to supported browsers like Google Chrome or Microsoft Edge to ensure add-on testing requests are received and processed.